{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:10:56Z","timestamp":1695467456996},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"13-14","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10354-022-01000-6","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T11:03:21Z","timestamp":1674644601000},"page":"339-345","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dissociation of clinical, laboratory, and bone biopsy findings in adult X-linked hypophosphatemia: a\u00a0case report"],"prefix":"10.1007","volume":"173","author":[{"given":"Roland","family":"Kocijan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Tilmann","family":"Mindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus Alexander","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danial Arian","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalbert","family":"Raimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Zwerina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"issue":"5\u20136","key":"1000_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s10354-019-00732-2","volume":"170","author":"A Raimann","year":"2020","unstructured":"Raimann\u00a0A, Mindler\u00a0GT, Kocijan\u00a0R, Bekes\u00a0K, Zwerina\u00a0J, Haeusler\u00a0G, et al. Multidisciplinary patient care in X\u2011linked hypophosphatemic rickets: one challenge, many perspectives. Wien Med Wochenschr. 2020;170(5\u20136):116\u201323.","journal-title":"Wien Med Wochenschr"},{"key":"1000_CR2","doi-asserted-by":"publisher","first-page":"754084","DOI":"10.3389\/fendo.2021.754084","volume":"12","author":"GT Mindler","year":"2021","unstructured":"Mindler\u00a0GT, Kranzl\u00a0A, Stauffer\u00a0A, Kocijan\u00a0R, Ganger\u00a0R, Radler\u00a0C, et al. Lower limb deformity and gait deviations among adolescents and adults with X\u2011linked hypophosphatemia. Front Endocrinol. 2021;12:754084.","journal-title":"Front Endocrinol"},{"issue":"6","key":"1000_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","volume":"18","author":"A Trombetti","year":"2022","unstructured":"Trombetti\u00a0A, Al-Daghri\u00a0N, Brandi\u00a0ML, Cannata-And\u00eda\u00a0JB, Cavalier\u00a0E, Chandran\u00a0M, et al. Interdisciplinary management of FGF23-related phosphate wasting syndromes: a\u00a0Consensus Statement on the evaluation, diagnosis and care of patients with X\u2011linked hypophosphataemia. Nat Rev Endocrinol. 2022;18(6):366\u201384.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"1000_CR4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00198-022-06318-w","volume":"33","author":"G Orlando","year":"2022","unstructured":"Orlando\u00a0G, Bubbear\u00a0J, Clarke\u00a0S, Keen\u00a0R, Roy\u00a0M, Anilkumar\u00a0A, et al. Physical function and physical activity in adults with X\u2011linked hypophosphatemia. Osteoporos Int. 2022;33(7):1485\u201391.","journal-title":"Osteoporos Int"},{"issue":"7","key":"1000_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00198-022-06385-z","volume":"33","author":"M Scorcelletti","year":"2022","unstructured":"Scorcelletti\u00a0M, Kara\u00a0S, Zange\u00a0J, Jordan\u00a0J, Semler\u00a0O, Sch\u00f6nau\u00a0E, et al. Lower limb bone geometry in adult individuals with X\u2011linked hypophosphatemia: an observational study. Osteoporos Int. 2022;33(7):1601\u201311.","journal-title":"Osteoporos Int"},{"issue":"5\u20136","key":"1000_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10354-020-00805-7","volume":"171","author":"GT Mindler","year":"2021","unstructured":"Mindler\u00a0GT, Stauffer\u00a0A, Ganger\u00a0R. Leg lengthening and deformity correction in rare bone diseases: a\u00a0multidisciplinary approach. Wien Med Wochenschr. 2021;171(5\u20136):126\u201332.","journal-title":"Wien Med Wochenschr"},{"issue":"5","key":"1000_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci\u00a0M, Collins\u00a0MT, Fedarko\u00a0NS, Cherman\u00a0N, Corsi\u00a0A, White\u00a0KE, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J\u00a0Clin Invest. 2003;112(5):683\u201392.","journal-title":"J Clin Invest"},{"issue":"6","key":"1000_CR8","doi-asserted-by":"publisher","first-page":"e10506","DOI":"10.1002\/jbm4.10506","volume":"5","author":"B Hadzimuratovic","year":"2021","unstructured":"Hadzimuratovic\u00a0B, Haschka\u00a0J, Hartmann\u00a0MA, Blouin\u00a0S, Fratzl-Zelman\u00a0N, Zwerina\u00a0J, et al. Impact of Tenofovir Disoproxil-induced Fanconi syndrome on bone material quality: a case report. JBMR Plus. 2021;5(6):e10506.","journal-title":"JBMR Plus"},{"issue":"7","key":"1000_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner\u00a0D, Emma\u00a0F, Eastwood\u00a0DM, Duplan\u00a0MB, Bacchetta\u00a0J, Schnabel\u00a0D, et al. Clinical practice recommendations for the diagnosis and management of X\u2011linked hypophosphataemia. Nat Rev Nephrol. 2019;15(7):435\u201355.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1000_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt\u00a0AM, Drezner\u00a0MK, Glorieux\u00a0FH, Kanis\u00a0JA, Malluche\u00a0H, Meunier\u00a0PJ, et\u00a0al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J\u00a0Bone Miner Res. 1987;2(6):595\u2013610.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1000_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster\u00a0DW, Compston\u00a0JE, Drezner\u00a0MK, Glorieux\u00a0FH, Kanis\u00a0JA, Malluche\u00a0H, et\u00a0al. Standardized nomenclature, symbols, and units for bone histomorphometry: a\u00a02012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J\u00a0Bone Miner Res. 2013;28(1):2\u201317.","journal-title":"J Bone Miner Res"},{"key":"1000_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/jcp.47.6.529","volume":"47","author":"MTA Rehman","year":"1994","unstructured":"Rehman\u00a0MTA, Hoyland\u00a0J, Denton\u00a0J, Freemont\u00a0A. Age related histomorphometric changes in bone in normal British men and women. J\u00a0Clin Pathol. 1994;47:529\u201334.","journal-title":"J Clin Pathol"},{"issue":"2","key":"1000_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00223-021-00832-5","volume":"109","author":"MA Hartmann","year":"2021","unstructured":"Hartmann\u00a0MA, Blouin\u00a0S, Misof\u00a0BM, Fratzl-Zelman\u00a0N, Roschger\u00a0P, Berzlanovich\u00a0A, et al. Quantitative backscattered electron imaging of bone using a\u00a0thermionic or a\u00a0field emission electron source. Calcif Tissue Int. 2021;109(2):190\u2013202.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1000_CR14","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1210\/clinem\/dgab739","volume":"107","author":"MK Javaid","year":"2022","unstructured":"Javaid\u00a0MK, Ward\u00a0L, Pinedo-Villanueva\u00a0R, Rylands\u00a0AJ, Williams\u00a0A, Insogna\u00a0K, et al. Musculoskeletal features in adults with X\u2011linked hypophosphatemia: an analysis of clinical trial and survey data. J\u00a0Clin Endocrinol Metab. 2022;107(3):e1249\u2013e62.","journal-title":"J Clin Endocrinol Metab"},{"key":"1000_CR15","doi-asserted-by":"publisher","first-page":"641543","DOI":"10.3389\/fendo.2021.641543","volume":"12","author":"MR Laurent","year":"2021","unstructured":"Laurent\u00a0MR, De Schepper\u00a0J, Trouet\u00a0D, Godefroid\u00a0N, Boros\u00a0E, Heinrichs\u00a0C, et al. Consensus recommendations for the diagnosis and management of X\u2011linked hypophosphatemia in Belgium. Front Endocrinol. 2021;12:641543.","journal-title":"Front Endocrinol"},{"key":"1000_CR16","doi-asserted-by":"publisher","first-page":"116423","DOI":"10.1016\/j.bone.2022.116423","volume":"160","author":"X Ni","year":"2022","unstructured":"Ni\u00a0X, Guan\u00a0W, Pang\u00a0Q, Jin\u00a0C, Gong\u00a0Y, Liu\u00a0W, et al. Bone microstructure evaluated by TBS and HR-pQCT in Chinese adults with X\u2011linked hypophosphatemia. Bone. 2022;160:116423.","journal-title":"Bone"},{"issue":"7","key":"1000_CR17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter\u00a0TO, Imel\u00a0EA, Holm\u00a0IA, de Beur\u00a0JSM, Insogna\u00a0KL. A clinician\u2019s guide to X\u2011linked hypophosphatemia. J\u00a0Bone Miner Res. 2011;26(7):1381\u20138.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"1000_CR18","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1210\/JC.2015-2199","volume":"100","author":"J Connor","year":"2015","unstructured":"Connor\u00a0J, Olear\u00a0EA, Insogna\u00a0KL, Katz\u00a0L, Baker\u00a0S, Kaur\u00a0R, et al. Conventional therapy in adults with X\u2011linked hypophosphatemia: effects on enthesopathy and dental disease. J\u00a0Clin Endocrinol Metab. 2015;100(10):3625\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1000_CR19","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI111900","volume":"75","author":"RM Harrell","year":"1985","unstructured":"Harrell\u00a0RM, Lyles\u00a0KW, Harrelson\u00a0JM, Friedman\u00a0NE, Drezner\u00a0MK. Healing of bone disease in X\u2011linked hypophosphatemic rickets\/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J\u00a0Clin Invest. 1985;75(6):1858\u201368.","journal-title":"J Clin Invest"},{"issue":"3","key":"1000_CR20","first-page":"879","volume":"75","author":"W Sullivan","year":"1992","unstructured":"Sullivan\u00a0W, Carpenter\u00a0T, Glorieux\u00a0F, Travers\u00a0R, Insogna\u00a0K. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X\u2011linked hypophosphatemic rickets. J\u00a0Clin Endocrinol Metab. 1992;75(3):879\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1000_CR21","doi-asserted-by":"publisher","first-page":"107556","DOI":"10.1016\/j.jsb.2020.107556","volume":"211","author":"N Fratzl-Zelman","year":"2020","unstructured":"Fratzl-Zelman\u00a0N, Gamsjaeger\u00a0S, Blouin\u00a0S, Kocijan\u00a0R, Plasenzotti\u00a0P, Rokidi\u00a0S, et al. Alterations of bone material properties in adult patients with X\u2011linked hypophosphatemia (XLH). J\u00a0Struct Biol. 2020;211(3):107556.","journal-title":"J Struct Biol"},{"issue":"6","key":"1000_CR22","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00198-021-06221-w","volume":"33","author":"C Jin","year":"2022","unstructured":"Jin\u00a0C, Zhang\u00a0C, Ni\u00a0X, Zhao\u00a0Z, Xu\u00a0L, Wu\u00a0B, et al. The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X\u2011linked hypophosphatemia: a\u00a0prospective study. Osteoporos Int. 2022;33(6):1385\u201395.","journal-title":"Osteoporos Int"},{"issue":"1","key":"1000_CR23","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EC-13-0103","volume":"3","author":"A Linglart","year":"2014","unstructured":"Linglart\u00a0A, Biosse-Duplan\u00a0M, Briot\u00a0K, Chaussain\u00a0C, Esterle\u00a0L, Guillaume-Czitrom\u00a0S, et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect. 2014;3(1):R13\u201330.","journal-title":"Endocr Connect"},{"issue":"1","key":"1000_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1297\/cpe.22.9","volume":"22","author":"M Fujiwara","year":"2013","unstructured":"Fujiwara\u00a0M, Namba\u00a0N, Ozono\u00a0K, Arisaka\u00a0O, Yokoya\u00a0S. Treatment of hypophosphatemic rickets with phosphate and active vitamin D in Japan: a questionnaire-based survey. Clin Pediatr Endocrinol. 2013;22(1):9\u201314.","journal-title":"Clin Pediatr Endocrinol"},{"issue":"5","key":"1000_CR25","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jpc.15976","volume":"58","author":"JL Sandy","year":"2022","unstructured":"Sandy\u00a0JL, Simm\u00a0PJ, Biggin\u00a0A, Rodda\u00a0CP, Wall\u00a0C\u2011L, Siafarikas\u00a0A, et al. Clinical practice guidelines for paediatric X\u2011linked hypophosphataemia in the era of burosumab. J\u00a0Paediatrics Child Health. 2022;58(5):762\u20138.","journal-title":"J Paediatrics Child Health"},{"issue":"3","key":"1000_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/clinem\/dgab796","volume":"107","author":"K Dahir","year":"2022","unstructured":"Dahir\u00a0K, Dhaliwal\u00a0R, Simmons\u00a0J, Imel\u00a0EA, Gottesman\u00a0GS, Mahan\u00a0JD, et al. Health care transition from pediatric- to adult-focused care in X\u2011linked hypophosphatemia: expert consensus. J\u00a0Clin Endocrinol Metab. 2022;107(3):599\u2013613.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1000_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1210\/js.2018-00338","volume":"3","author":"PI Colares Neto Gd","year":"2019","unstructured":"Colares Neto Gd\u00a0PI, Yamauchi\u00a0F, Hueb Baroni\u00a0R, de Andrade Bianchi\u00a0M, Cavalanti Gomes\u00a0A, Chammas\u00a0MC, et al. Nephrocalcinosis and nephrolithiasis in X\u2011linked hypophosphatemic rickets: diagnostic imaging and risk factors. J\u00a0Endocr Soc. 2019;3(5):1053\u201361.","journal-title":"J Endocr Soc"},{"issue":"7","key":"1000_CR28","first-page":"A4874","volume":"61","author":"LH Nielsen","year":"2014","unstructured":"Nielsen\u00a0LH, Rahbek\u00a0ET, Beck-Nielsen\u00a0SS, Christesen\u00a0HT. Treatment of hypophosphataemic rickets in children remains a\u00a0challenge. Dan Med\u00a0J. 2014;61(7):A4874.","journal-title":"Dan Med J"},{"issue":"5","key":"1000_CR29","doi-asserted-by":"publisher","first-page":"bvac021","DOI":"10.1210\/jendso\/bvac021","volume":"6","author":"N Namba","year":"2022","unstructured":"Namba\u00a0N, Kubota\u00a0T, Muroya\u00a0K, Tanaka\u00a0H, Kanematsu\u00a0M, Kojima\u00a0M, et al. Safety and efficacy of burosumab in pediatric patients with X\u2011linked hypophosphatemia: a phase 3\/4 open-label trial. J\u00a0Endocr Soc. 2022;6(5):bvac21.","journal-title":"J Endocr Soc"},{"issue":"3","key":"1000_CR30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1210\/clinem\/dgab729","volume":"107","author":"A Linglart","year":"2022","unstructured":"Linglart\u00a0A, Imel\u00a0EA, Whyte\u00a0MP, Portale\u00a0AA, H\u00f6gler\u00a0W, Boot\u00a0AM, et al. Sustained efficacy and safety of burosumab, a\u00a0monoclonal antibody to FGF23, in children with X\u2011linked hypophosphatemia. J\u00a0Clin Endocrinol Metab. 2022;107(3):813\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"1000_CR31","doi-asserted-by":"publisher","first-page":"866170","DOI":"10.3389\/fendo.2022.866170","volume":"13","author":"GT Mindler","year":"2022","unstructured":"Mindler\u00a0GT, Stauffer\u00a0A, Kranzl\u00a0A, Penzkofer\u00a0S, Ganger\u00a0R, Radler\u00a0C, et al. Persistent lower limb deformities despite amelioration of rickets in X\u2011linked hypophosphatemia (XLH)\u2014a prospective observational study. Front Endocrinol. 2022;13:866170.","journal-title":"Front Endocrinol"},{"issue":"8","key":"1000_CR32","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"KL Insogna","year":"2018","unstructured":"Insogna\u00a0KL, Briot\u00a0K, Imel\u00a0EA, Kamenick\u00fd\u00a0P, Ruppe\u00a0MD, Portale\u00a0AA, et al. A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X\u2011linked Hypophosphatemia: week 24 primary analysis. J\u00a0Bone Miner Res. 2018;33(8):1383\u201393.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1000_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","volume":"105","author":"AA Portale","year":"2019","unstructured":"Portale\u00a0AA, Carpenter\u00a0TO, Brandi\u00a0ML, Briot\u00a0K, Cheong\u00a0HI, Cohen-Solal\u00a0M, et al. Continued beneficial effects of Burosumab in adults with X\u2011linked hypophosphatemia: results from a\u00a024-week treatment continuation period after a\u00a024-week double-blind placebo-controlled period. Calcif Tissue Int. 2019;105(3):271\u201384.","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"1000_CR34","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jbmr.3843","volume":"34","author":"KL Insogna","year":"2019","unstructured":"Insogna\u00a0KL, Rauch\u00a0F, Kamenick\u00fd\u00a0P, Ito\u00a0N, Kubota\u00a0T, Nakamura\u00a0A, et al. Burosumab improved histomorphometric measures of osteomalacia in adults with X\u2011linked hypophosphatemia: a phase 3, single-arm, international trial. J\u00a0Bone Miner Res. 2019;34(12):2183\u201391.","journal-title":"J Bone Miner Res"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-01000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10354-022-01000-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-01000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T08:13:08Z","timestamp":1695370388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10354-022-01000-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":34,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1007\/s10354-022-01000-6","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"28 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.\u00a0Kocijan, G.\u00a0Mindler, and A.\u00a0Raimann have received speaker honoraria from Kyowa Kirin. The Ludwig Boltzmann Institute of Osteology has received a\u00a0research grant form Ultragenyx. M.\u00a0Hartmann, D.\u00a0A.\u00a0Kraus, and J.\u00a0Zwerina state no other conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}